Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
University of Arizona
University of Arizona
Mayo Clinic
University of Texas Southwestern Medical Center
University of Milano Bicocca
M.D. Anderson Cancer Center
Indiana University
Brown University
OHSU Knight Cancer Institute
Big Ten Cancer Research Consortium
University of California, Irvine
Peter MacCallum Cancer Centre, Australia
Abramson Cancer Center at Penn Medicine